Location: | Dundee |
---|---|
Salary: | £36,924 to £45,163 |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 18th October 2024 |
---|---|
Closes: | 16th November 2024 |
Job Ref: | 5026 |
We are recruiting highly motivated postdoctoral researchers to participate in a new academic-industrial global initiative supported by the Michael J Fox Foundation for Parkinson’s Research. The project aims to: (1) Explore and validate new approaches to target LRRK2; (2) Perform systematic mechanistic, structural and safety analyses to benchmark new LRRK2 modifiers that emerge from this effort and (3) identify clinically relevant biomarkers for LRRK2-driven Parkinson’s disease that will facilitate the selection of patients who respond to LRRK2 inhibitor therapy. We aim to galvanise research and accelerate the development of Parkinson’s disease therapeutics. These positions enable further training in state-of-th e-art methods through the course of the project, and involve wider collaboration with Protein Phosphorylation and Ubiquitylation Unit members, other academic Institutions worldwide and industrial partners working in this area.
The appointed post holders will be based within the laboratories of Dario Alessi, Esther Sammler and Paul Davies within the University of Dundee’s MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU, www.ppu.mrc.ac.uk).
The successful applicant will have previous knowledge and expertise in one or more of the following areas:
Your priorities will include:
Who we’re looking for:
Type / Role:
Subject Area(s):
Location(s):